Provider
Biologic Immunomodulators - FocusRx (For Pharmacy Benefits Only) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Documents & Forms Results
Displaying 3591 - 3600 of 3636 results
Provider
Zeposia (ozanimod) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Sodium-glucose Co-transporter (SGLT) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Daybue (trofinetide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Long Acting Insulin - Commercial
Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Insulin Pumps - Commercial
Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Arikayce - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Erythropoietins - Commercial
Prior Authorization
Program effective Date: Apr 01, 2026
Provider
Insulin Combination Agents (Soliqua, Xultophy) - Commercial
Quantity Limit
Program effective Date: Apr 01, 2026
Provider
Risdiplam - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2026